Vericiguat outcomes by pre-randomisation worsening heart failure events: a post-hoc recurrent events analysis of the VICTOR trial

28 August 2026 (14:39 - 14:57)
Organised by: Logo
Congress Presentation Part of: Therapy for HFrEF: improving outcomes in the real world Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology